Human Genome Epidemiology Literature Finder
Records 1 - 22 (of 22 Records) |
Query Trace: Gastroesophageal Reflux and CYP2C19[original query] |
---|
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clinical pharmacology and therapeutics 2002 Oct 72 (4): 453-60. Furuta Takahisa, Shirai Naohito, Watanabe Fumitoshi, Honda Satoru, Takeuchi Ken, Iida Takayuki, Sato Yoshihiko, Kajimura Masayoshi, Futami Hajime, Takayanagi Shigekazu, Yamada Masami, Ohashi Kyoichi, Ishizaki Takashi, Hanai Hiroyu |
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data. Clinical pharmacology and therapeutics 2005 Dec 78 (6): 627-34. Schwab Matthias, Klotz Ulrich, Hofmann Ute, Schaeffeler Elke, Leodolter Andreas, Malfertheiner Peter, Treiber Gerha |
[Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2006 Sep 48 (3): 162-71. Sohn Young Hae, Lee Wan Sik, Park Chang Hwan, Joo Young Eun, Kim Hyun Soo, Choi Sung Kyu, Rew Jong Sun, Kim Sei Jo |
Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease. Journal of gastroenterology and hepatology 2007 Aug 22 (8): 1286-92. Lee Yi-Chia, Lin Jaw-Town, Wang Hsiu-Po, Chiu Han-Mo, Wu Ming-Shia |
Influences of CYP2C19 polymorphism on recurrence of reflux esophagitis during proton pump inhibitor maintenance therapy. Hepato-gastroenterology 0 56 (91-92): 703-6. Saitoh Toshihito, Otsuka Hiroko, Kawasaki Takahiro, Endo Hitoshi, Iga Daijirou, Tomimatsu Masahiko, Fukushima Yasushi, Katsube Takao, Ogawa Kenji, Otsuka Kunia |
A comparative study of proton-pump inhibitor tests for Chinese reflux patients in relation to the CYP2C19 genotypes. Journal of clinical gastroenterology 0 43 (10): 920-5. Tseng Ping-Huei, Lee Yi-Chia, Chiu Han-Mo, Wang Hsiu-Po, Lin Jaw-Town, Wu Ming-Shia |
CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole. European journal of clinical pharmacology 2009 Jul 65 (7): 693-8. Furuta Takahisa, Sugimoto Mitsushige, Kodaira Chise, Nishino Masafumi, Yamade Mihoko, Ikuma Mutsuhiro, Shirai Naohito, Watanabe Hiroshi, Umemura Kazuo, Kimura Michio, Hishida Aki |
Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole. Journal of clinical pharmacology 2010 Mar 50 (3): 320-30. Sugimoto Mitsushige, Nishino Masafumi, Kodaira Chise, Yamade Mihoko, Ikuma Mutsuhiro, Tanaka Tatsuo, Sugimura Haruhiko, Hishida Akira, Furuta Takahi |
Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis. Archives of Iranian medicine 2010 Sep 13 (5): 406-12. Zendehdel Nader, Biramijamal Firouzeh, Hossein-Nezhad Arash, Zendehdel Nasrin, Sarie Hamidreza, Doughaiemoghaddam Masoud, Pourshams Akr |
[Detection of cytochrome P4502C19 gene polymorphism to optimize therapy of acid-dependent diseases]. Klinicheskaia meditsina 2015 93 (1): 46-50. Klyaritskaya I L, Rabotyagova Yu |
Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. Journal of clinical pharmacology 2016 Mar . Liu Dongyang, Yang Hong, Jiang Ji, Nagy Péter, Shen Kai, Qian Jiaming, Hu P |
Association Between CYP2C19*17 Alleles and pH Probe Testing Outcomes in Children With Symptomatic Gastroesophageal Reflux. Journal of clinical pharmacology 2017 Sep . Franciosi James P, Mougey Edward B, Williams Andre, Gomez-Suarez Roberto A, Thomas Cameron, Creech Christa L, George Katherine, Corao Diana, Lima John |
Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment. European journal of pediatrics 2017 Dec . Franciosi James P, Mougey Edward B, Williams Andre, Gomez Suarez Roberto A, Thomas Cameron, Creech Christa L, George Katherine, Corao Diana, Lima John |
Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers. Journal of clinical pharmacology 2017 12 58 (4): 425-433. Toda Ryoko, Shiramoto Masanari, Komai Emi, Yoshii Kazuyoshi, Hirayama Masamichi, Kawabata Yoshihi |
Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease. Cureus 2018 7 10 (5): e2687. Zheng Connor L, Alzghari Saeed |
Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2021 Aug e14217. Yasuda Jessica L, Staffa Steven J, Nurko Samuel, Kane Madeline, Wall Stephanie, Mougey Edward B, Franciosi James P, Manfredi Michael A, Rosen Rach |
Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PloS one 2021 16 (1): e0245401. Arévalo-Galvis Azucena, Otero-Regino William A, Ovalle-Celis Gloria N, Rodríguez-Gómez Eliana R, Trespalacios-Rangel Alba |
Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus. Frontiers in genetics 2022 6 13 869160. Kee Ping Siu, Maggo Simran D S, Kennedy Martin A, Barclay Murray L, Miller Allison L, Lehnert Klaus, Curtis Maurice A, Faull Richard L M, Parker Remai, Chin Paul K |
The Role of Endoplasmic Reticulum Stress in Gastroesophageal Reflux Disease Symptoms and Treatment. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023 5 34 (5): 533-541. Elmas Kasap, Tahir Buran, Aysun Toraman Avcu, P?nar Solmaz Hasdemir, Erdal Balcan, Ça?da? Aktan, Mehmet Korkm |
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes. Archives of pharmacal research 2023 12 . Chang-Keun Cho, Eunvin Ko, Ju Yeon Mo, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Jung-Woo Bae, Chang-Ik Ch |
Correlation analysis and prognostic value of miR-29a-3p expression and CYP2C19 genotypes in exfoliated cells from tongue coating of patients with gastroesophageal reflux disease. Genes & genomics 2023 1 . Zhang Aiqing, Liu Wenjuan, Niu Lingyun, Zhu Liping, Yang Liuqing, Li Xuelia |
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease. Journal of the Canadian Association of Gastroenterology 2024 6 7 (3): 238-245. Cheng-Chun Tai, Samantha Medwid, Keith Mclntosh, Nilesh Chande, Richard B Kim, James Greg |
- Page last reviewed:Feb 1, 2024
- Content source: